VitaNova Life Sciences (VNOV) Enterprise Value (2022 - 2026)

VitaNova Life Sciences has disclosed Enterprise Value across 5 years of filings, most recently posting $9.9 million for Q3 2026.

• Enterprise Value for Q3 2026 came in at $9.9 million, down 20.53% year-over-year; the trailing twelve-month figure through Jul 2026 was $9.9 million (down 20.53% YoY), and the FY2026 annual result was $9.9 million, down 22.13% from the prior year.
• Enterprise Value for Q3 2026 stood at $9.9 million, roughly flat from $9.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at $119.5 million in Q4 2025 and bottomed at $9.0 million in Q2 2022.
• Average Enterprise Value over 5 years is $26.4 million, with a median of $13.3 million recorded in 2024.
• The widest annual swing landed in 2024, when Enterprise Value tumbled 74.45%; it then surged 799.97% in 2025.
• Year by year, Enterprise Value stood at $35.2 million in 2022, then plunged by 69.97% to $10.6 million in 2023, then advanced by 25.7% to $13.3 million in 2024, then jumped by 799.97% to $119.5 million in 2025, then slumped by 91.72% to $9.9 million in 2026.
• The last three Enterprise Value figures came in at $9.9 million (Q3 2026), $9.9 million (Q2 2026), and $39.1 million (Q1 2026), per Business Quant data.